Risk of all-cause mortality and transcontinental differences in angiopoietin-like 4 protein and lipids in patients admitted with chest pain of suspected coronary origin.
The prognostic utility of angiopoietin-like 4 protein (ANGPTL4) has previously been explored [1). ANGPTL4 plays a key role in lipid and glucose metabolism. It inhibits lipoprotein lipase (LPL) and is positively related to increased triglyceride (TG) levels and risk of cardiovascular death. Sharing the same protoc...